127 related articles for article (PubMed ID: 37480200)
1. Association of EDN levels in patients with asthma and correlation with FEV
Kuai S; Zhao P
Allergy Asthma Proc; 2023 Jul; 44(4):244-251. PubMed ID: 37480200
[No Abstract] [Full Text] [Related]
2. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
[TBL] [Abstract][Full Text] [Related]
3. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
4. Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics.
Badar A; Hussain MM; Saeed W; Aslam M
J Pak Med Assoc; 2010 Feb; 60(2):97-101. PubMed ID: 20209693
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
Kim CK; Callaway Z; Kim DW; Kita H
J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
Kim CK; Callaway Z; Fletcher R; Koh YY
J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
[TBL] [Abstract][Full Text] [Related]
7. Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts.
An J; Lee JH; Sim JH; Song WJ; Kwon HS; Cho YS; Moon HB; Kim CK; Kim TB
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2681-2688.e1. PubMed ID: 32304842
[TBL] [Abstract][Full Text] [Related]
8. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
Lung; 2007; 185(2):97-103. PubMed ID: 17393238
[TBL] [Abstract][Full Text] [Related]
9. Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics.
Lee Y; Lee JH; Yang EM; Kwon E; Jung CG; Kim SC; Choi Y; Cho YS; Kim CK; Park HS
Allergy Asthma Immunol Res; 2019 May; 11(3):394-405. PubMed ID: 30912328
[TBL] [Abstract][Full Text] [Related]
10. Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthma.
Omony J; Thölken C; Salimi A; Laubhahn K; Illi S; Weckmann M; Grychtol R; Rabe KF; Thiele D; Foth S; Weber S; Brinkmann F; Kopp MV; Hansen G; Renz H; von Mutius E; Schaub B; Skevaki C;
Pediatr Allergy Immunol; 2024 Jun; 35(6):e14172. PubMed ID: 38873905
[TBL] [Abstract][Full Text] [Related]
11. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma.
Kim CK; Callaway Z; Park JS; Kwon E
Allergol Int; 2017 Jan; 66(1):70-74. PubMed ID: 27329145
[TBL] [Abstract][Full Text] [Related]
12. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma.
Morioka J; Kurosawa M; Inamura H; Nakagami R; Mizushima Y; Chihara J; Yokoseki T; Kitamura S; Omura Y; Shibata M
Int Arch Allergy Immunol; 2000 May; 122(1):49-57. PubMed ID: 10859469
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil-derived neurotoxin levels in early childhood and association with preschool asthma - A prospective observational study.
Färdig M; Lie A; Borres MP; Ekenkrantz T; Granum B; Haugen G; Jonassen CM; Movérare R; Rehbinder EM; Skjerven HO; Cathrine A; Vettukattil R; Lødrup Carlsen KC; Söderhäll C; Nordlund B
Clin Exp Allergy; 2023 Nov; 53(11):1198-1211. PubMed ID: 37795650
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
Kim HS; Yang HJ; Song DJ; Lee YJ; Suh DI; Shim JY; Yoo Y; Kim CK; Ahn YM; Kim JT
Allergy Asthma Proc; 2022 Mar; 43(2):133-139. PubMed ID: 35317890
[No Abstract] [Full Text] [Related]
16. Changes in Type 2 Biomarkers After Anti-IL5 Treatment in Patients With Severe Eosinophilic Asthma.
Jang JH; Woo SD; Lee Y; Kim CK; Shin YS; Ye YM; Park HS
Allergy Asthma Immunol Res; 2021 Mar; 13(2):330-338. PubMed ID: 33474865
[TBL] [Abstract][Full Text] [Related]
17. Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
Granger V; Zerimech F; Arab J; Siroux V; de Nadai P; Tsicopoulos A; Matran R; Akiki Z; Nadif R
Thorax; 2022 Jun; 77(6):552-562. PubMed ID: 34615736
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker.
Rutten B; Young S; Rhedin M; Olsson M; Kurian N; Syed F; Beech A; Fidock M; Newbold P; Singh D; Platt A; Hughes G
PLoS One; 2021; 16(2):e0246627. PubMed ID: 33566823
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
[TBL] [Abstract][Full Text] [Related]
20. The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN).
Rutten B; Young S; Aldridge S; Davies R; Fidock M; Newbold P; Singh D; Platt A; Hughes G
J Immunol Methods; 2022 Jan; 500():113181. PubMed ID: 34762913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
